Mesothelioma Survivor Rising with Immunotherapy – Asbestos.com (blog)
Asbestos.com (blog) |
Mesothelioma Survivor Rising with Immunotherapy
Asbestos.com (blog) Hartline, who was first diagnosed in July 2016, has been receiving the experimental immunotherapy drug nivolumab – also known by brand name Opdivo – for the last seven months. He returns to Balaraman’s nearby office every two weeks for an hour of IV … |
Toronto Star |
Sick Kids scientists repair genetic errors in mice with muscular dystrophy
Toronto Star Science magazine hailed the gene editing tool, CRISPR, as the breakthrough of the year in 2015. The new research is part of a wave of effort to push CRISPR from its early experimental promise toward real-life therapies. “It’s not just something that … |
|
Immunotherapy Moves Into Rare Skin Cancer Type
Curetoday.com Despite being about 40 times less common than melanoma, mortality rates are far higher because it’s so aggressive: About 40 percent of patients will experience a recurrence, and, until the discovery of effective immunotherapy in 2016, more than 30 … |
|
CRISPR used to record a film in bacteria
BioNews Scientists have used the CRISPR/Cas system to encode a movie in the genomes of living bacteria. However, the researchers’ ultimate goal is not to record movies or to ‘put Wikipedia into bacteria’, said first author Dr Seth Shipman from Harvard … |
|
‘Incredibly Exciting’: CAR T Cells as ‘Living Drugs’
Medscape “Incredibly exciting” is how experts are describing the new development with chimeric antigen receptor (CAR) T cells, as the first of these novel therapies approaches the market. After last week’s unanimous vote in favor of recommending approval by the … |
CBS New York |
FDA gives preliminary approval for CAR T-cell therapy
fox2now.com ST. LOUIS, Mo. _ A new treatment is on the horizon for people suffering from cancer, specifically Leukemia. The FDA has given its preliminary approval for CAR T-Cell Therapy. It’s based on a person’s own genes. Dr. Mark Fesler, Oncologist with SLUCare … ‘Astounding’ gene therapy cancer drug heading for FDA approvalWCVB Boston T–cell cancer therapy holds promise, longer-term results awaitBusiness Insider Novel Gene Therapy for Leukemia Clears FDA PanelScientific American myfox8.com –Toronto Sun –Biotechin.Asia all 57 news articles » |